A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 39,362 shares of JAZZ stock, worth $4.89 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
39,362
Previous 8,070 387.76%
Holding current value
$4.89 Million
Previous $861,000 409.52%
% of portfolio
0.01%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.57 - $116.37 $3.15 Million - $3.64 Million
31,292 Added 387.76%
39,362 $4.39 Million
Q2 2024

Aug 08, 2024

SELL
$103.94 - $118.98 $6.83 Million - $7.82 Million
-65,687 Reduced 89.06%
8,070 $861,000
Q1 2024

May 10, 2024

BUY
$115.19 - $132.77 $4.83 Million - $5.57 Million
41,950 Added 131.89%
73,757 $8.88 Million
Q4 2023

Feb 09, 2024

SELL
$114.26 - $136.0 $538,393 - $640,832
-4,712 Reduced 12.9%
31,807 $3.91 Million
Q3 2023

Nov 09, 2023

SELL
$122.0 - $145.31 $150,304 - $179,021
-1,232 Reduced 3.26%
36,519 $4.73 Million
Q2 2023

Aug 08, 2023

BUY
$122.5 - $147.16 $52,430 - $62,984
428 Added 1.15%
37,751 $4.68 Million
Q1 2023

May 10, 2023

BUY
$133.98 - $160.47 $203,247 - $243,432
1,517 Added 4.24%
37,323 $5.46 Million
Q4 2022

Feb 10, 2023

BUY
$129.72 - $159.85 $206,903 - $254,960
1,595 Added 4.66%
35,806 $5.7 Million
Q3 2022

Nov 10, 2022

BUY
$126.59 - $161.18 $115,450 - $146,996
912 Added 2.74%
34,211 $4.56 Million
Q2 2022

Aug 09, 2022

SELL
$141.59 - $168.66 $599,208 - $713,769
-4,232 Reduced 11.28%
33,299 $5.2 Million
Q1 2022

May 12, 2022

SELL
$129.64 - $160.7 $3.97 Million - $4.92 Million
-30,647 Reduced 44.95%
37,531 $5.84 Million
Q4 2021

Feb 09, 2022

SELL
$119.87 - $145.67 $1.66 Million - $2.02 Million
-13,850 Reduced 16.88%
68,178 $8.69 Million
Q3 2021

Nov 12, 2021

BUY
$128.64 - $184.79 $495,006 - $711,071
3,848 Added 4.92%
82,028 $10.7 Million
Q2 2021

Aug 12, 2021

BUY
$160.2 - $186.42 $2.71 Million - $3.15 Million
16,921 Added 27.62%
78,180 $14.1 Million
Q1 2021

May 12, 2021

SELL
$150.19 - $173.5 $677,206 - $782,311
-4,509 Reduced 6.86%
61,259 $10.1 Million
Q4 2020

Feb 12, 2021

BUY
$140.71 - $165.05 $310,406 - $364,100
2,206 Added 3.47%
65,768 $10.9 Million
Q3 2020

Nov 12, 2020

BUY
$105.46 - $144.13 $380,394 - $519,876
3,607 Added 6.02%
63,562 $9.06 Million
Q2 2020

Sep 11, 2020

BUY
$95.68 - $121.88 $1.2 Million - $1.53 Million
12,558 Added 26.5%
59,955 $6.62 Million
Q2 2020

Aug 13, 2020

SELL
$95.68 - $121.88 $337,941 - $430,480
-3,532 Reduced 6.94%
47,397 $6.62 Million
Q1 2020

May 13, 2020

SELL
$87.74 - $152.74 $148,192 - $257,977
-1,689 Reduced 3.21%
50,929 $5.08 Million
Q4 2019

Feb 14, 2020

BUY
$117.65 - $153.73 $431,775 - $564,189
3,670 Added 7.5%
52,618 $7.86 Million
Q3 2019

Nov 12, 2019

SELL
$125.18 - $143.24 $590,098 - $675,233
-4,714 Reduced 8.78%
48,948 $6.23 Million
Q2 2019

Aug 07, 2019

BUY
$125.55 - $144.48 $468,678 - $539,343
3,733 Added 7.48%
53,662 $7.41 Million
Q1 2019

May 13, 2019

BUY
$121.81 - $142.95 $600,645 - $704,886
4,931 Added 10.96%
49,929 $7 Million
Q4 2018

Feb 12, 2019

SELL
$115.94 - $166.74 $16,347 - $23,510
-141 Reduced 0.31%
44,998 $5.58 Million
Q3 2018

Nov 13, 2018

SELL
$161.01 - $180.57 $12.2 Million - $13.7 Million
-75,936 Reduced 62.72%
45,139 $7.59 Million
Q2 2018

Aug 10, 2018

BUY
$146.33 - $183.18 $133,745 - $167,426
914 Added 0.76%
121,075 $20.9 Million
Q1 2018

May 11, 2018

SELL
$135.59 - $157.16 $19,931 - $23,102
-147 Reduced 0.12%
120,161 $18.1 Million
Q4 2017

Feb 09, 2018

BUY
$131.06 - $150.39 $78,373 - $89,933
598 Added 0.5%
120,308 $16.2 Million
Q3 2017

Nov 13, 2017

BUY
$142.62 - $155.6 $17.1 Million - $18.6 Million
119,710
119,710 $17.5 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.79B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.